Norges Bank’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,073,724
Closed -$166M 2244
2016
Q4
$166M Sell
2,073,724
-52,778
-2% -$4.19M 0.07% 264
2016
Q3
$162M Sell
2,126,502
-554,949
-21% -$44.8M 0.08% 256
2016
Q2
$209M Buy
2,681,451
+475,076
+22% +$33.9M 0.1% 198
2016
Q1
$121M Buy
2,206,375
+18,519
+0.8% +$1.01M 0.06% 302
2015
Q4
$135M Sell
2,187,856
-196,930
-8% -$12.4M 0.07% 273
2015
Q3
$150M Buy
2,384,786
+27,330
+1% +$1.95M 0.08% 250
2015
Q2
$172M Buy
2,357,456
+40,711
+2% +$2.94M 0.09% 225
2015
Q1
$152M Buy
2,316,745
+176,652
+8% +$11.7M 0.07% 261
2014
Q4
$139M Hold
2,140,093
0.07% 268
2014
Q3
$129M Sell
2,140,093
-2,172,539
-50% -$142M 0.07% 269
2014
Q2
$299M Buy
4,312,632
+2,156,316
+100% +$140M 0.08% 235
2014
Q1
$141M Hold
2,156,316
0.08% 234
2013
Q4
$134M Sell
2,156,316
-406,279
-16% -$23.5M 0.08% 241
2013
Q3
$137M Sell
2,562,595
-37,872
-1% -$1.95M 0.08% 245
2013
Q2
$119M Buy
+2,600,467
New +$113M 0.07% 262

Other funds holding STJ

Norges Bank's STJ Position: Q1 2017 in Review

Norges Bank sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,073,724 shares — an estimated $166M sold.

Norges Bank first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $299M in Q2 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Norges Bank reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Norges Bank sold 2,073,724 St Jude Medical shares in Q1 2017, an estimated $166M.
  • Norges Bank first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • Norges Bank's St Jude Medical position peaked at $299M in Q2 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Norges Bank's 13F filing for Q1 2017, filed 10 May 2017.